- Home
- MYNZ
MYNZ
Mainz Biomed N.V.
as 11-11-2025 11:35am EST
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
| Founded: | 2021 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 7.9M | IPO Year: | 2021 |
| Target Price: | $14.00 | AVG Volume (30 days): | 139.0K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.28 - $14.39 | Next Earning Date: | 12-29-2025 |
| Revenue: | $659,935 | Revenue Growth: | -28.05% |
| Revenue Growth (this year): | -0.28% | Revenue Growth (next year): | 5.03% |
Latest Mainz Biomed N.V. News
MYNZ Breaking Stock News: Dive into MYNZ Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Mainz Biomed to Attend 2025 Maxim Growth Summit
GlobeNewswire
a month ago
Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
GlobeNewswire
3 months ago
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
GlobeNewswire
5 months ago
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
Medical Device Network
5 months ago
Mainz begins next phase of project to develop pancreatic cancer blood test
GlobeNewswire
5 months ago
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
GOBankingRates
5 months ago
7 Summer Side Hustles That Can Pay $1,000 a Week or More
Yahoo Finance Video
5 months ago
Will Tesla have to play catch up to Waymo's robotaxis?
Compare MYNZ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MYNZ Mainz Biomed N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.